PDAC is dominated by KRAS signaling. To reveal these hidden vulnerabilities, we turned to pancreatic acinar cell carcinoma (ACC), a rare KRAS-independent pancreatic malignancy that offers a unique biological window beyond KRAS-driven oncogenesis.